<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BCL-6 mutations are accumulated during B-cell transit through the germinal center (GC) and provide a histogenetic marker for B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>On the basis of a comprehensive analysis of 308 B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, we (1) expand the spectrum of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> associated with BCL-6 mutations; (2) corroborate the notion that mutations cluster with GC and post-GC B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo>; and (3) identify <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> mutation frequency among B-lineage diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (B-DLCL) subsets </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations are virtually absent in <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (P &lt;.001) and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (P &lt;.05), whereas they occur frequently in GC or post-GC <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, including lymphoplasmacytoid <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, MALT <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, B-DLCL and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Among B-DLCL, mutations occur frequently in systemic nodal B-DLCL, primary extranodal B-DLCL, CD5(+) B-DLCL, CD30(+) B-DLCL, and primary splenic B-DLCL, suggesting a similar histogenesis of these B-DLCL subsets </plain></SENT>
<SENT sid="4" pm="."><plain>Conversely, mutations are rare in primary mediastinal B-DLCL with <z:mp ids='MP_0000612'>sclerosis</z:mp> (10.0%; P &lt;.01), supporting a distinct histogenesis for this <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Longitudinal follow-up of B-DLCL transformed from follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> shows that they BCL-6 mutations may accumulate during histologic progression </plain></SENT>
<SENT sid="6" pm="."><plain>Mutations also occur in some B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemias</z:hpo>, small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and hairy cell <z:hpo ids='HP_0001909'>leukemias</z:hpo>, consistent with the hypothesis that a fraction of these lymphoproliferations are related to GC-like cells </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, the molecular pattern of 193 mutational events reinforces the hypothesis that mutations of BCL-6 and immunoglobulin genes are caused by similar mechanisms </plain></SENT>
<SENT sid="8" pm="."><plain>(Blood </plain></SENT>
<SENT sid="9" pm="."><plain>2000;95:651-659) </plain></SENT>
</text></document>